Natco Pharma disclosed a marginal decline in consolidated net profit for the quarter ended September 2015. During the quarter, the profit of the company declined 8.65% to Rs 295.70 million from Rs 323.70 million in the same quarter previous year.
Revenues for the quarter rose 7.15% to Rs 2,349.00 million, compared with Rs 2,192 million for the prior year period.
Operating margin for the quarter stood at 24.90 percent as compared to 26.84 percent for the previous year period. Operating Income for the quarter was Rs 584.90 million, compared with Rs 588.5 million in the previous year period.
Earnings per share for the quarter stood at Rs 8.84, registering 9.70% decline over previous year period.
Quarterly Results - Consolidated (Rs in mn) |
As at | Sep - 15 | Sep - 14 | %Change |
Revenues | 2,349.00 | 2,192.30 | 7.15 |
Net Profit | 295.70 | 323.70 | (8.65) |
Diluted EPS | 8.84 | 9.79 | (9.70) |
Shares of the company declined Rs 3.25, or 0.13%, to settle at Rs 2,458. The total volume of shares traded was 6,138 at the BSE (Friday).